Canadian Cancer Trials Group (CCTG) LY.17: A Randomized Phase II Study Evaluating Novel Salvage Therapy Pre-Autologous Stem Cell Transplant (ASCT) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) - Outcome of Rituximab-Dose-Intensive Cyclophosphamide, Etoposide, Cisplatin (R-DICEP) Versus R-GDP
| Autor: | Stewart, Douglas A., Shepherd, Lois E., Dudebout, Jill J. *, Larouche, Jean-François, Chua, Neil *, Baetz, Tara *, Crump, Michael, Shafey, Mona, Abdel-Samad, Nizar, Robinson, Sue *, Fleury, Isabelle, Marcellus, Deborah *, Skrabek, Pamela, Kelly, Jesse *, Hay, Annette E., Chen, Bingshu *, Kuruvilla, John |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3734-3736 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|